Amylin

Bristol-Myers to close Amylin's headquarters in San Diego and cut about 300 jobs

Bristol-Myers to close Amylin's headquarters in San Diego and cut about 300 jobs

Yahoo/AP

Takeda and Amylin terminate obesity compound co-development agreement

Takeda and Amylin terminate obesity compound co-development agreement

equities.com

Takeda writes off its $1B obesity deal with Amylin

Takeda writes off its $1B obesity deal with Amylin

Fierce Biotech

Novo Nordisk says new data show Victoza advantage

Novo Nordisk says new data show Victoza advantage

Reuters

3 Diabetes Phase 3 Wins

3 Diabetes Phase 3 Wins

Motley Fool

Lilly Backs Broad Diabetes Range to Challenge Rivals

Lilly Backs Broad Diabetes Range to Challenge Rivals

Bloomberg

Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up

Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up

Bloomberg

Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts

Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts

Seeking Alpha

3 Things to Watch in the Pharmaceutical Sector Right Now

3 Things to Watch in the Pharmaceutical Sector Right Now

Motley Fool

Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term

Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term

Seeking Alpha